GSK
Yu Liu Ho has extensive experience in clinical pharmacology, with a focus on oncology. Currently serving as Senior Director at GSK since January 2023, previous roles include Senior Director of Clinical Pharmacology at Sierra Oncology and a consulting position at ClinPharm, specializing in DMPK, PK/PD, and toxicology from April 2013 to March 2022. Earlier positions include Director and Assistant Director of Preclinical/Clinical Pharmacology at Neuro Therapeutics Pharma, along with work as a Clinical Pharmacology Consultant. Yu Liu Ho holds dual Ph.D. degrees in Bioengineering from the University of California, Berkeley, and the University of California, San Francisco.
This person is not in any teams
This person is not in any offices